1. X-linked inhibitor of apoptosis protein (XIAP) predicts disease-free survival in BRAFV600E mutant papillary thyroid carcinoma in middle eastern patients
   Sandeep Kumar Parvathareddy et al, 2022, Frontiers in Endocrinology CrossRef
2. TROP2 is a Good Indicator for Infiltrative Nature of Carcinoma Rather than Diagnosing Malignancy in Thyroid
   E. Kılınc et al, 2022, Indian Journal of Otolaryngology and Head & Neck Surgery CrossRef
3. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
   Tanner Fullmer et al, 2021, Frontiers in Endocrinology CrossRef
4. Editorial: Targeting different programmed cell death processes as therapeutic modalities for thyroid cancer
   Sadegh Rajabi, 2023, Frontiers in Endocrinology CrossRef
5. Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma
   Xiaojing Wei et al, 2022, BioMed Research International CrossRef
6. Analysis of the association of BRAFV600E mutation and Ki-67 overexpression with clinical and pathological characteristics in papillary thyroid cancer
   Maira Espenbetova et al, 2021, Radiation and Environmental Biophysics CrossRef
7. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage
   Yin-zhu Zhao et al, 2022, Frontiers in Endocrinology CrossRef